StudyFinder

Multimodality Therapy with Immunotherapy in Stage I-IIIA Pleural Mesothelioma

Status: Recruiting

The purpose of this study is to compare the usual treatment alone to using the usual treatment plus surgery.

I'm interested

Sex: Male or Female
Age Group: 18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• daignosis of Sarcomatoid or sarcomatoid-dominant (> 50%) biphasic, pleural mesothelioma
• have not received treatment
• not pregnant or breastfeeding
• able to do all selfcare but may be unable to carry out any work activities; up and about more than 50% of waking hours
• see link to clinicaltrials.gov for complete inclusion criteria
Exclusion Criteria:

• people who are not able to have surgical treatment
• history of symptomatic interstitial lung disease
• see link to clinicaltrials.gov for complete exclusion criteria
Interventions:

Procedure: Computed Tomography, Biological: Ipilimumab, Procedure: Magnetic Resonance Imaging, Biological: Nivolumab, Procedure: Positron Emission Tomography, Procedure: Surgical Procedure

Conditions:

Cancer

Keywords:

Clinics and Surgery Center (CSC), lung cancer, Mesothelioma

Study Contact: Robert Kratzke - kratz003@umn.edu
Principal Investigator: Robert Kratzke
Phase: PHASE2
IRB Number: STUDY00026290
See this study on ClinicalTrials.gov

Back